AC
MYOV

Amia Capital’s Myovant Sciences Ltd. MYOV Stock Holding History

Amia Capital’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-25,111
Closed -$353K – 32
2020
Q3 		$353K Sell
25,111
-1,959
-7% -$36.4K 0.41% 26
2020
Q2 		$558K Sell
27,070
-14,900
-36% -$203K 0.46% 22
2020
Q1 		$317K Sell
41,970
-11,538
-22% -$129K 0.28% 27
2019
Q4 		$830K Buy
+53,508
New +$539K 0.24% 29

Other funds holding MYOV

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
PC
Pier Capital Stamford, Connecticut $606M AUM 63.41% 1-Year Est. Return

Amia Capital's MYOV Position: Q4 2020 in Review

Amia Capital sold out of Myovant Sciences Ltd. (MYOV) in Q4 2020, closing a stake of 25,111 shares — an estimated $353K sold.

Amia Capital first reported a position in MYOV in Q4 2019 and held it in 4 quarters. The position peaked at $830K in Q4 2019. 105 funds tracked by Wall St. Rank hold MYOV as of Q4 2020.

  • Amia Capital reported no remaining Myovant Sciences Ltd. position as of Q4 2020 after selling out during the quarter.
  • Amia Capital sold 25,111 Myovant Sciences Ltd. shares in Q4 2020, an estimated $353K.
  • Amia Capital first reported a position in Myovant Sciences Ltd. in Q4 2019 and held it in 4 quarters.
  • Amia Capital's Myovant Sciences Ltd. position peaked at $830K in Q4 2019.
  • 105 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q4 2020.

Based on Amia Capital's 13F filing for Q4 2020, filed 11 Feb 2021.